U.S. General Merchandise and Department Stores Stock News

Over the past six months, Genesis Energy released softer quarterly results alongside a multi-year revenue decline, weaker gross margins than sector peers, and elevated debt levels, prompting investors to reassess the company’s fundamentals. This combination of shrinking revenue, structurally thin margins, and higher financial leverage has raised questions about the resilience of Genesis Energy’s business model relative to alternatives. With these concerns about low gross margins in mind,...

Recent commentary on Bank of Hawaii highlights weak net interest income growth, a low net interest margin and minimal earnings per share growth, raising fresh questions about the bank’s loan profitability and earnings power as of mid‑2026. An interesting angle is that these profitability concerns are emerging while the bank’s shares still trade at a premium valuation to peers, sharpening investor focus on the strength of its underlying fundamentals. We’ll now examine how concerns about Bank...

Northern Trust has been appointed by Invesco to administer and provide custody for new Irish domiciled index tracking mutual funds. The mandate covers a synthetic index replication structure that extends an approach previously used in ETFs to a wider mutual fund investor base in Europe. Northern Trust, traded as NasdaqGS:NTRS, is adding this new Invesco mandate at a time when its stock has seen strong recent returns. The shares closed at $191.125, with the stock up 6.2% over the past week,...

Domino's Pizza stock has fallen 31.9% over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and the market multiples currently point to the shares trading at a discount to their assessed worth. That sets up a clear tension for investors trying to judge whether the recent weakness has already priced in the key risks around margins, competition and consumer demand. Over the past 12 months, the share price decline of 31.9% raises the question of...

Earlier this week, Taysha Gene Therapies announced an underwritten public offering of 32.5 million common shares at US$6.00 each after releasing updated Part A REVEAL study data for TSHA-102 in Rett syndrome. The new REVEAL data positions TSHA-102 as a potential first disease-modifying gene therapy for Rett syndrome, which could be important for both patients and Taysha’s gene therapy platform. With fresh REVEAL Part A data supporting TSHA-102’s disease-modifying potential, we’ll examine how...

NeoGenomics (NEO) has drawn fresh attention after announcing FDA approval and the commercial launch of PTEN IHC CDx, an immunohistochemistry companion diagnostic for prostate adenocarcinoma patients with PTEN deficiency. See our latest analysis for NeoGenomics. The PTEN IHC CDx launch lands at a time when momentum in NeoGenomics’ stock has been building, with a 30.75% 1 month share price return and 77.70% 3 month share price return, while the 1 year total shareholder return of 109.84%...

Happen Inc. has recently rebranded and launched the Happen Bank brand while listing its shares on the Nasdaq under the ticker HAPN, marking a shift toward offering simple, clear and easy-to-use financial products. This combination of a fresh brand identity and public listing signals an effort to broaden Happen’s reach as a consumer-focused financial platform. Next, we’ll examine how Happen’s launch of Happen Bank and Nasdaq listing shape the company’s existing investment narrative and risk...

Earlier this month, Pharvaris announced that the FDA accepted its New Drug Application for deucrictibant immediate-release 20 mg capsules for on-demand treatment of Hereditary Angioedema attacks, supported by Phase 3 RAPIDe-3 data covering more than 1,300 treated attacks. The filing showcases an oral bradykinin B2 receptor antagonist that achieved rapid symptom relief, End of Progression, and complete attack resolution with statistical significance across all primary and secondary endpoints...

PDD Holdings (PDD) recently outpaced the broader market with a 2.18% gain as attention shifted to its upcoming earnings report, which combines an expected EPS decline with projected revenue growth. See our latest analysis for PDD Holdings. At a share price of $85.74, PDD Holdings has seen a 2.62% 30 day share price return, but its year to date share price return is down 25.93% and the 1 year total shareholder return is down 18.44%, even as its 3 year total shareholder return is up 13.97%...

Accel Entertainment (ACEL) stock is drawing attention after the company announced several leadership changes, including the promotion of Toucan Gaming chief executive Stan Guidroz to Chief Operating Officer and the outlining of a planned transition for its compliance leadership. See our latest analysis for Accel Entertainment. Accel Entertainment’s leadership reshuffle comes after a mixed stretch for the stock, with the share price down 6.25% over the past month but ahead for the year with an...

Horace Mann Educators (HMN) is back in focus after industry commentary highlighted its niche focus, product updates, pricing approach and distribution model as potential supports for first quarter results among multiline insurance peers. See our latest analysis for Horace Mann Educators. Horace Mann Educators’ recent pullback, with the share price down 2.54% over one day and 4.60% over seven days to $50.97, comes after a stronger run that includes a 13.92% 90 day share price return and a...

CNA Financial stock is coming off a strong three year run, with returns of 66.9%. Valuation checks and an intrinsic value estimate based on an Excess Returns model still suggest the shares trade at a discount to their calculated worth, while traditional earnings multiples look roughly in line with the market. Over the last three years, CNA Financial has returned 66.9%, putting recent momentum and earlier buyers in profit territory. The company is investing heavily in artificial intelligence,...

Earlier this week, Habitat for Humanity International announced that Lowe's renewed its longstanding national partnership, funding grants for more than 200 home repair and rehab projects across 20 affiliates to help over 300 individuals remain in their homes. This renewed commitment highlights Lowe's ongoing role in essential housing support, including critical repairs, energy efficiency upgrades, accessibility improvements, and disaster preparedness for vulnerable communities. We'll now...

UnitedHealth Group is facing expanded U.S. Department of Justice antitrust scrutiny focused on its Claritev health technology unit. The DOJ has reportedly issued new civil investigative demands that include allegations of collusion with major insurers. The investigation now addresses both market competition and pricing practices, going beyond the company’s previously disclosed antitrust matters. UnitedHealth Group, traded on the NYSE as NYSE:UNH, is coming under closer regulatory attention...

Lakeland Financial stock has delivered a 22.3% total return over the past three years, yet its current valuation signals are split, with the Excess Returns intrinsic value estimate pointing to meaningful upside while earnings based multiples suggest the shares are on the expensive side. That tension leaves investors weighing a stock that screens as 37.0% undervalued on one model but overvalued on traditional ratios, with a mixed overall value score. Over the past three years, Lakeland...

Olin and Huntsman received SEC effectiveness for their joint S-4 Registration Statement. This advances their planned merger of equals to form a combined chemicals company valued at over $12b. The S-4 effectiveness is a key step toward closing the transaction, subject to remaining approvals and conditions. For investors watching Olin (NYSE:OLN), the SEC’s sign off on the S-4 comes as the stock trades around $21.86. The shares are up 4.1% over the past week, but down 13.6% over the past...

We can readily understand why investors are attracted to unprofitable companies. For example, Century Therapeutics...

Insiders who acquired US$128.6k worth of Quoin Pharmaceuticals, Ltd.'s ( NASDAQ:QNRX ) stock at an average price of...

The United States market has remained flat over the past week but has seen a significant increase of 21% over the past year, with earnings projected to grow by 18% annually. In this context, identifying promising small-cap stocks with notable insider activity can offer unique opportunities for investors seeking to capitalize on potential growth within a dynamic market landscape.

The United States market has remained flat over the past week but has experienced a significant 21% rise over the last year, with earnings projected to grow by 18% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability, positioning themselves well to capitalize on future opportunities in a dynamic economic environment.

In the last week, the United States market has been flat, yet it has seen a 21% increase over the past year with earnings forecasted to grow by 18% annually. In this context of growth and stability, identifying stocks trading below their intrinsic value can present potential opportunities for investors looking to capitalize on undervalued assets.

In the last week, the market has been flat, but it is up 21% over the past year with earnings expected to grow by 18% per annum over the next few years. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.

Over the last 7 days, the United States market has remained flat, though it has risen 21% over the past year with earnings forecasted to grow by 18% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

In the last week, the United States market has been flat, yet it remains up 21% over the past year with earnings forecasted to grow by 18% annually. In this environment, dividend stocks can offer a compelling opportunity for investors seeking steady income and potential capital appreciation.